Breast Cancer News and Research

Latest Breast Cancer News and Research

AVEO announces results from tivozanib Phase 1b clinical trial for advanced gastrointestinal cancers

AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced results from a Phase 1b clinical trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with FOLFOX6, a standard chemotherapy regimen, in patients with advanced gastrointestinal (GI) cancers.

19 Nov 2010

Volpara breast imaging software receives FDA clearance

Offering radiologists a reliable and cost-effective tool to generate automatic volumetric breast density values, Volpara, Ltd., announced today that it has received clearance from the U.S. Food & Drug Administration for its Volpara breast imaging software. Volpara, a subsidiary of Matakina Technology, Limited of New Zealand, is responsible for commercial operations in the United States.

19 Nov 2010

Clinical data of CU-201, CUDC-101 presented at EORTC-NCI-AACR Symposium

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of data in two poster presentations at the 22nd EORTC-NCI-AACR Symposium on "Molecular Targets and Cancer Therapeutics," held in Berlin, Germany, November 16-19.

19 Nov 2010

COPD both a burden and a loss

Patients with Chronic Obstructive Pulmonary Disease, or COPD, revealed that they perceive their disease as both a burden they must deal with and as a loss they have experienced, according to recent in-home research conducted by GlaxoSmithKline. Patients participating in the research characterized their sense of loss as a combination of factors including loss of energy, loss of control, loss of independence and loss of their old self.

18 Nov 2010

Multidisciplinary clinic approach can improve survival in patients with aggressive prostate cancer

A research team from the National Cancer Institute (NCI) designated Kimmel Cancer Center (KCC) at Jefferson has concluded for the first time that a multidisciplinary clinic approach to aggressive prostate cancer can improve survival in patients. The results from the 15-year study of the multidisciplinary clinic can be found in the November issue of Journal of Oncology Practice.

18 Nov 2010

DiaGenic receives 92,738,974 shares in subsequent offering

Preliminary counts indicate that DiaGenic has received subscriptions for approximately 92,738,974 shares in the subsequent offering closed yesterday.

18 Nov 2010

New technique to identify cancer biomarkers

The University of Liège has presented TARGETOME, the most recent of its spin-offs, which is also the first to spring from its applied geno-proteomics centre, GIGA.

18 Nov 2010

MK-4827 drug candidate shows promising anti-tumour activity in first human trial

A new drug that targets proteins responsible for helping cancer cells to repair damage to their DNA has shown promising anti-tumour activity in its first trial in humans.

18 Nov 2010

Exelixis reports interim data of XL184 for metastatic castration-resistant prostate cancer

Exelixis, Inc. today reported interim data from the cohort of patients with metastatic castration-resistant prostate cancer (CRPC) treated with XL184 in an ongoing phase 2 adaptive randomized discontinuation trial (RDT).

18 Nov 2010

Scientists develop new method for detecting functional sites on proteins

A team led by scientists from The Scripps Research Institute has developed a powerful new method for detecting functional sites on proteins. The technique may have broad applications in basic research and drug development.

18 Nov 2010

Exelixis reports interim data from phase 2 RDT trial for epithelial ovarian cancer

Exelixis, Inc. today reported interim data from the cohort of patients with advanced epithelial ovarian cancer, primary peritoneal, or fallopian tube carcinoma treated with XL184 in an ongoing phase 2 adaptive randomized discontinuation trial (RDT).

18 Nov 2010

U-Systems initiates EASY study for screening breast cancer

U-Systems, the leader in Automated Breast Ultrasound technology announced participant enrollment has begun in the European Asymptomatic Screening Study (EASY) at Capio Saint Göran Hospital, in Stockholm, Sweden.

18 Nov 2010

Cancer patients can still access NICE rejected drugs

Anti cancer drugs that have been rejected by the UK Government’s new cancer drugs fund would still be available to needy patients according to the new ‘top-up’ cash plan that is being launched. This Health Top-Up cash plan comes from Western Provident Association (WPA).

17 Nov 2010

Mammograms bungled: Rush to fix the problem

Nearly 5,300 mammograms will need a review because of a computer error at Breast Screen Victoria. In a serious error a radiologist noticed a mismatch between the names of patients and their images. This may mean that some women may not have had their mammograms checked twice by two different radiologists as is the usual protocol.

17 Nov 2010

Risk of radiation-induced breast cancer from mammographic screening slight in comparison to benefits

The risk of radiation-induced breast cancer from mammography screening is slight in comparison to the benefit of expected lives saved, according to a new study appearing online and in the January issue of the journal Radiology.

17 Nov 2010

Targeted therapies could treat a broad range of cancers: Research

Targeted cancer therapies such as trastuzumab (Herceptin), gefitinib (Iressa) and erlotinib (Tarceva) could be used to treat a wider range of cancers than previously thought, according to new research presented today (Wednesday) at the 22nd EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Berlin.

17 Nov 2010

New OncoMap technique can detect point mutation in ovarian cancer

Researchers have shown that point mutations mis-spellings in a single letter of genetic code that drive the onset and growth of cancer cells can be detected successfully in advanced ovarian cancer using a technique called OncoMap. The finding opens the way for personalised medicine in which every patient could have their tumour screened, specific mutations identified, and the appropriate drug chosen to target the mutation and halt the growth of their cancer.

17 Nov 2010

Enzon presents data on three investigational mRNA antagonists at EORTC-NCI-AACR Symposium

Enzon Pharmaceuticals, Inc. today presented data from preclinical studies of three investigational messenger RNA (mRNA) antagonists. These antagonists are based on the locked nucleic acid (LNA) technology platform targets licensed from Santaris Pharma A/S.

17 Nov 2010

Study: EGFR inhibtion may help treat triple negative breast cancer

Scientists believe they may have found a new target for treating triple negative breast cancer - one of the more difficult breast cancers to treat successfully and for which there is no targeted therapy at present.

17 Nov 2010

AVEO commences enrollment in Phase 1b combination trial of tivozanib with oral capecitabine in advanced tumors

AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that it has initiated patient enrollment in an open-label, multi-center Phase 1b clinical trial evaluating tivozanib in combination with oral capecitabine (Xeloda®) in patients with certain advanced solid tumors.

17 Nov 2010

Breast Cancer News and Research

Latest Breast Cancer News and Research

AVEO announces results from tivozanib Phase 1b clinical trial for advanced gastrointestinal cancers

Volpara breast imaging software receives FDA clearance

Clinical data of CU-201, CUDC-101 presented at EORTC-NCI-AACR Symposium

COPD both a burden and a loss

Multidisciplinary clinic approach can improve survival in patients with aggressive prostate cancer

DiaGenic receives 92,738,974 shares in subsequent offering

New technique to identify cancer biomarkers

MK-4827 drug candidate shows promising anti-tumour activity in first human trial

Exelixis reports interim data of XL184 for metastatic castration-resistant prostate cancer

Scientists develop new method for detecting functional sites on proteins

Exelixis reports interim data from phase 2 RDT trial for epithelial ovarian cancer

U-Systems initiates EASY study for screening breast cancer

Cancer patients can still access NICE rejected drugs

Mammograms bungled: Rush to fix the problem

Risk of radiation-induced breast cancer from mammographic screening slight in comparison to benefits

Targeted therapies could treat a broad range of cancers: Research

New OncoMap technique can detect point mutation in ovarian cancer

Enzon presents data on three investigational mRNA antagonists at EORTC-NCI-AACR Symposium

Study: EGFR inhibtion may help treat triple negative breast cancer

AVEO commences enrollment in Phase 1b combination trial of tivozanib with oral capecitabine in advanced tumors

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Breast Cancer News and Research

Latest Breast Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in